PDCD1 and cancer: These targeted genes were enriched in immune-suppressive signaling pathways, including the negative regulation of focal adhesion assembly, negative regulation of chemotaxis, negative regulation of cell-substrate junction organization, negative regulation of B cell proliferation, and PD-L1 expression and PD-1 checkpoint pathway in cancer (Figure S4F).